The Effects of Aplindore on the Treatment of Signs and Symptoms of Restless Legs Syndrome
Clinical trial NCT00626418 · COMPLETED
Trial details
- NCT number
- NCT00626418
- Sponsor
- Ligand Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2008-10-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.